Response to Bridging Therapy as a Prognostic Indicator of Post-Transplantation Hepatocellular Carcinoma Recurrence and Survival: A Systematic Review

Paweł Topolewski, Dariusz Łaski, Martyna Łukasiewicz, Piotr Domagała, Roeland F de Wilde, Wojciech G Polak, Maen Abdelrahim · 2024

Read Response to Bridging Therapy as a Prognostic Indicator of Post-Transplantation Hepatocellular Carcinoma Recurrence and Survival: A Systematic Review by Paweł Topolewski, Dariusz Łaski, Martyna Łukasiewicz, Piotr Domagała, Roeland F de Wilde, Wojciech G Polak, Maen Abdelrahim (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11592521.txt.

Description

Paweł Topolewski and co-authors review whether a liver cancer patient's response to pre-transplant treatment predicts how they fare after a liver transplant, in a 2024 systematic review. Bridging therapy treats the tumor while the patient waits for a donor organ. Whether response to it forecasts recurrence and survival was unsettled.

Searching two databases under standard review rules, the team found five studies. Four carried a serious risk of bias and one a moderate risk, which tempers the findings. Patients whose scans showed a complete or partial response tended to do best after transplant. Poor response or growth during bridging went with worse survival. Data were too thin to judge tissue-based response. The authors urge future transplant scoring models to fold in scan, tissue, and molecular features of the tumor.

Catalog record

CREATORPaweł Topolewski, Dariusz Łaski, Martyna Łukasiewicz, Piotr Domagała, Roeland F de Wilde, Wojciech G Polak, Maen Abdelrahim
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE35 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11592521

Browse the full library · About the Tower of Babel